期刊文献+

^125I-脱氧尿嘧啶核苷对淋巴瘤细胞Raji和Daudi的杀伤作用 被引量:1

Killing effect of ^125I-UdR on human lymphoma Raji and Daudi cell lines
原文传递
导出
摘要 目的探讨^125I-脱氧尿嘧啶核苷(^125I-UdR)在淋巴瘤细胞Raji和Daudi中的特异性摄取及其杀伤效应。方法测量Raft、Daudi细胞和细胞核在含不同放射性浓度^125I-UdR的培养液中培养不同时间后的活度;用噻唑蓝(MTT)实验和碘化丙啶(PI)染色周期分析评价^125I-UdR对Raji和Daudi细胞的杀伤作用。结果Raji和Daudi细胞摄取^125I-UdR的量明显高于Na^125I对照组(P〈0.05),在100kBq/ml浓度时,Raji和Daudi细胞摄取^125I-UdR的量分别为(14414±95)和(6916±53.69)Bq/10^6细胞,而对Na^125I的摄取量分别为(68±3.8)和(324±32.8)Bq/10^6细胞;细胞和细胞核中^125I-UdR的量随培养基中^125I-UdR放射性浓度以及培养时间的增加而增加;^125I-UdR组的存活分数明显低于Na^125I对照组(P〈0.05),以500kBq/ml浓度培养48h时,Raji和Daudi细胞^125I.UdR组的存活分数分别为(19.78±1.39)%和(43.17±2.69)%,而Na^125I组的存活分数分别为(79.10±1.79)%和(80.36±6.12)%;细胞存活分数有随培养基中放射性浓度增加而降低的趋势。结论^125I-UdR可被Raji和Daudi细胞特异性摄取并进入细胞核中,进而杀死细胞,其作用具有明显的时间-效应和剂量-效应关系。 Objective To evaluate the killing effect and the uptake of ^125I-UdR on human lymphoma Raji and Daudi cell lines. Methods The amount of ^125I-UdR in the cells and cell nuclei were determined after incubation of different time in RPMI 1640 culturing medium containing different concentrations of ^125I-UdR. The killing effects of ^125I-UdR on Raji and Daudi cell lines were estimated through MTF assay and cell cycle was analyzed by propidium iodide (PI) staining. Results The amounts of ^125I-UdR in Raji and Daudi ceils and cell nuclei were much higher than that of Na^125I( P 〈 0.05). The amounts of ^125I-UdR in Raji and Daudi cells were 14 414 ± 95 and (6916 ± 53.69) Bq/10^6 cell when the concentration was 100 kBq/ml. The amounts of Na^125I were 68 ± 3.8 and (324 ± 32.8) Bq/10^6 cell. The uptake of ^125I-UdR in Raji and Daudi cells and cell nuclei increased with the ^125I-UdR concentration and incubated time. The cell surviving fractions of ^125I-UdR groups was much lower than that of Na^125Igroups (P 〈 0.05). When the concentration was 500 kBq/ml and incubated time was 48 hours, the Raji and Daudi cell surviving fractions of ^125I-UdR groups were (19.78 ± 1.39)% and (43.17±2.69)%; those of Na^125I groups were( 79.10 ± 1.79)% and (80.36 ± 6.12)%. The surviving fractions of ^125I-UdR groups reduced with the ^125I -UdR concentration. Conclusions ^125I-UdR can be specially ingested by Raji and Daudi cells and incorporated into DNA, then the cells will be killed. The uptake of ^125I-UdR is dose and time dependent.
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2009年第1期50-53,共4页 Chinese Journal of Radiological Medicine and Protection
关键词 淋巴瘤细胞 Raji DAUDI ^125I-UdR 摄取 杀伤效应 Lymphoma cells Raji Daudi ^125I-UdR Uptake Killing effect
  • 相关文献

参考文献9

  • 1Zager JS, Delman KA, Ebright MI, et al. Use of radiolabelled iododeoxyuridine as adjuvant treatment for experimental tumours of the liver. Br J Surg, 2003,90(10) : 1225-1231.
  • 2Buchegger F, Adamer F, Schaffland AO, et al. Highly efficient DNA incorporation of intratumourally injected [ J]. iododeoxyur/dine under thymidine synthesis blocking in human glioblastoma xenografts. Int J Cancer, 2004,110 ( 1 ) : 145-149.
  • 3Chi KH, Wang HE, Chen FD, et al. Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model. J Nucl Med, 2001,42 (2): 345-351.
  • 4Semnani ES, Wang K, Adelstein SJ, et al. 5-[^123Ⅰ/^125Ⅰ] iodo-2'- deoxyuridine in metastatic lung cancer : radiopharmaceutical formulation affects targeting. J Nucl Med, 2005,46 (5) : 800-806.
  • 5Dupertuis YM, Xiao WH, Nicolas DT, et al. Unlabelled iododeoxyuridine increases the rate of uptake of [ ^125Ⅰ] iododeoxyuridine in human xenografted glioblastomas. Eur J Nucl Med, 2002,29 (4) : 499-505.
  • 6李金泉,鲍耀东,周岱,吴翼伟,江一民,王博诚,金坚.^(125)IUdR对人脑胶质瘤细胞SHG44的杀伤作用[J].核技术,2001,24(11):881-884. 被引量:11
  • 7Mariani G, Collecchi P, Baldassarri S, et al. Tumor uptake and mitotic activity pattern of 5- [ ^125 Ⅰ] iodo-2'-deoxyuridine after intravesical infusion in patients with bladder cancer. J Nucl Med, 1996,37(Suppl) : 16s-19s.
  • 8Macapirdac HA, Kemeny N, Daghighian F, et al. Pilot clinical trail of 5-[^125 Ⅰ] iodo-2'-deoxyuridine in the treatment of colorectal cancer metastatic to the liver. J Nuel Med, 1996, 37( Suppl) : 25s-29s.
  • 9Zager JS, Delman KA, Ebright MI, et al. Use of radiolabelled iododeoxyuridine as adjuvant treatment for experimental tumours of the liver. Br J Surg, 2003,90(10):1225-1231.

二级参考文献1

  • 1杜子威,中华肿瘤杂志,1984年,6卷,241页

共引文献10

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部